Metraipolis › archive › dc_0f9e2fb65b09

Chemokine Ligand-3 (CCL3) as a Novel Mediator of Inflammatory Bowel Disease Activity — Europe PMC PMID:42707155

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42707155
DOI
10.1016/j.gastha.2026.101081
License (as archived)
solo-consultazione
Archived
2026-10-17T04:07:18.502Z
SHA-256 of the archived text
ac1e89a02f3f0f3713bebd854ebabf3dc9416c5233c306c4df555884b60b7fe5
Stable URL of this page
https://metraipolis.com/documento/dc_0f9e2fb65b09

How to cite

Chemokine Ligand-3 (CCL3) as a Novel Mediator of Inflammatory Bowel Disease Activity — Europe PMC PMID:42707155 — Europe PMC (en), https://europepmc.org/article/MED/42707155 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0f9e2fb65b09 (Metraipolis archive dc_0f9e2fb65b09, sha256 ac1e89a02f3f0f3713bebd854ebabf3dc9416c5233c306c4df555884b60b7fe5)
BibTeX
@misc{dc0f9e2fb65b09,
  title = {Chemokine Ligand-3 (CCL3) as a Novel Mediator of Inflammatory Bowel Disease Activity — Europe PMC PMID:42707155},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42707155},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0f9e2fb65b09; sha256 ac1e89a02f3f0f3713bebd854ebabf3dc9416c5233c306c4df555884b60b7fe5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42707155. Agents can read the archived copy with the MCP tool read_document.